scientific-skills/Data Analysis/flow-cytometry-gating-strategist/SKILL.md
Recommend optimal flow cytometry gating strategies for specific cell types and fluorophores
npx skillsauth add aipoch/medical-research-skills flow-cytometry-gating-strategistInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
4 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Recommend optimal flow cytometry gating strategies for given cell types and fluorophores.
# Recommended format: comma-separated cell types and fluorophores
python scripts/main.py "CD4+ T cells,CD8+ T cells" "FITC,PE,APC"
# Or specify parameters separately
python scripts/main.py --cell-types "CD4+ T cells,CD8+ T cells" --fluorophores "FITC,PE,APC"
# Support more options
python scripts/main.py \
--cell-types "B cells" \
--fluorophores "FITC,PE,PerCP-Cy5.5,APC" \
--instrument "BD FACSCanto II" \
--purpose "cell sorting"
| Parameter | Type | Default | Required | Description |
|-----------|------|---------|----------|-------------|
| --cell-types | string | - | Yes | Comma-separated list of cell types (e.g., "CD4+ T cells,CD8+ T cells") |
| --fluorophores | string | - | Yes | Comma-separated list of fluorophores (e.g., "FITC,PE,APC") |
| --instrument | string | - | No | Flow cytometer model (e.g., "BD FACSCanto II") |
| --purpose | string | analysis | No | Purpose (analysis, cell sorting, screening) |
| --output, -o | string | stdout | No | Output file path for JSON results |
{
"recommended_strategy": {
"name": "Sequential Gating Strategy",
"description": "Gating based on FSC-A/SSC-A, followed by fluorescence intensity analysis",
"steps": [
{
"step": 1,
"gate": "FSC-A vs SSC-A",
"purpose": "Identify target cell population, exclude debris and dead cells",
"recommendation": "Set oval gate in lymphocyte region"
}
]
},
"fluorophore_recommendations": [
{
"fluorophore": "FITC",
"channel": "BL1",
"detector": "530/30",
"considerations": ["May spillover with GFP"]
}
],
"panel_optimization": {
"suggestions": ["Recommend pairing weakly expressed antigens with bright fluorophores"],
"avoid_combinations": ["FITC and GFP used simultaneously"]
},
"compensation_notes": ["FITC and PE require careful compensation"],
"quality_control": ["Recommend setting FMO controls", "Use viability dyes to exclude dead cells"]
}
| Fluorophore | Excitation Wavelength | Emission Wavelength | Detection Channel | |------|---------|---------|---------| | FITC | 488nm | 525nm | BL1 | | PE | 488nm | 575nm | YL1/BL2 | | PerCP | 488nm | 675nm | RL1 | | PerCP-Cy5.5 | 488nm | 695nm | RL1 | | PE-Cy7 | 488nm | 785nm | RL2 | | APC | 640nm | 660nm | RL1 | | APC-Cy7 | 640nm | 785nm | RL2 | | BV421 | 405nm | 421nm | VL1 | | BV510 | 405nm | 510nm | VL2 | | BV605 | 405nm | 605nm | VL3 | | BV650 | 405nm | 650nm | VL4 | | BV785 | 405nm | 785nm | VL6 | | DAPI | 355nm | 461nm | UV | | PI | 488nm | 617nm | YL2 |
Applicable scenario: Simple immunophenotyping analysis
Applicable scenario: Complex cell subset analysis
Applicable scenario: High-dimensional data (>15 colors)
Applicable scenario: Discovery of unknown cell populations
v1.0.0 - Initial version, supports basic gating strategy recommendations
| Risk Indicator | Assessment | Level | |----------------|------------|-------| | Code Execution | Python scripts with tools | High | | Network Access | External API calls | High | | File System Access | Read/write data | Medium | | Instruction Tampering | Standard prompt guidelines | Low | | Data Exposure | Data handled securely | Medium |
No additional Python packages required.
tools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.